Director Sells 50,000 Shares of Digital Health Platform Stock for $1.9 Million, According to Recent SEC Filing

50,000 Class A shares were sold on April 1, 2026, with a transaction value of ~$1.92 million based on a weighted average price of $38.46 per share. This disposition represented 100.00% of Mecklenburg's direct Class A Common Stock holdings at the time, reducing his direct Class A position to zero.

The Motley Fool • Apr 6, 2026

Hinge Health to announce first quarter 2026 financial results on May 5, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations websit.

Business Wire • Apr 2, 2026

Here's Why You Should Add Hinge Health Stock to Your Portfolio Now

HNGE pairs rapid growth and AI-driven efficiency with rising execution risks as 2026 slowdown, margin pressure, and engagement reliance cloud outlook.

Zacks Investment Research • Apr 2, 2026

Hinge Health now supports over 300 public sector organizations including 24 state governments

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced its expansion throughout the public sector, now delivering musculoskeletal (MSK) care to employees across 24 state employee health plan clients. With MSK conditions continuing to be a top healthcare cost driver, leading state governments are taking a different approach, prioritizing early intervention, accessibility, and evidence-based care that meets employees where they are. “Providing our team with a digital prog.

Business Wire • Mar 31, 2026

Hinge Health appoints Tyler Sloat to its board of directors

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. “Tyler brings decades of deep operating experience,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “His track record of scaling public companies wit.

Business Wire • Mar 17, 2026

Hinge Health Inc. (HNGE) Up 17.2% Since Last Earnings Report: Can It Continue?

Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Mar 12, 2026

Wall Street Analysts Predict a 26.25% Upside in Hinge Health Inc. (HNGE): Here's What You Should Know

The mean of analysts' price targets for Hinge Health Inc. (HNGE) points to a 26.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • Mar 9, 2026

Hinge Health's AI Moat Might Be Its Patient Movement Data

The cost of healthcare in the United States is on the rise in a big way. In its 2026 healthcare outlook, the Big Four accounting firm PricewaterhouseCoopers (PwC) made strong statements confirming this reality.

MarketBeat • Feb 23, 2026

The High‑Growth Healthcare Stock Early Investors Will Brag About for the Next Decade

Hinge Health is using artificial intelligence to keep physical therapy costs down for employers. The company improved revenue by 51% in 2025.

The Motley Fool • Feb 20, 2026

How Much Upside is Left in Hinge Health Inc. (HNGE)? Wall Street Analysts Think 38.96%

The average of price targets set by Wall Street analysts indicates a potential upside of 39% in Hinge Health Inc. (HNGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research • Feb 20, 2026